RSV Antibiotic Drivers And Resource-use (RADAR)

Dr. Behcet Uz Children's Hospital

Status: Completed

Conditions: Respiratory Syncytial Virus Infections; Antibiotic Stewardship in Community Hospitals

Study type: Observational

Funder types: Other

Identifiers

NCT06977971

2021-634

Details and patient eligibility

About

This study retrospectively evaluated the clinical, laboratory, and radiologic factors that influence the decision to prescribe antibiotics in children under 2 years of age hospitalized with RSV-positive acute lower respiratory tract infections. The study also examined the economic impact of antibiotic use in these patients. The goal is to improve clinical decision-making and reduce unnecessary antibiotic exposure in children with viral infections.

Full description

This retrospective, single-center study aimed to assess the clinical decision-making process regarding antibiotic prescription in children aged 1 to 24 months hospitalized with RSV-positive acute lower respiratory tract infections (ALRTI). The study was conducted at Dr. Behçet Uz Children's Hospital and covered four consecutive RSV seasons (April 2017 - April 2021). RSV infection was confirmed via multiplex PCR.

Clinical and laboratory variables potentially influencing antibiotic use included fever, respiratory distress, CRP levels, leukocyte count, and radiologic findings such as infiltrates on chest X-ray. The study also examined whether antibiotic selection (agent, timing, and duration) was associated with specific clinical profiles or severity indicators.

Hospitalization cost data were analyzed to estimate the economic burden of antibiotic use in RSV-positive patients. The study contributes to improved antimicrobial stewardship by identifying patterns of potentially unnecessary antibiotic prescriptions in viral respiratory infections.

Ethical approval was obtained from the local ethics committee (Approval No: 2021-634), and the study adhered to the principles of the Declaration of Helsinki.

Enrollment: 209 patients

Sex: All

Ages: 1 to 24 months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age between 1 and 24 months at the time of hospitalization
• Laboratory-confirmed RSV positivity via multiplex PCR
• Hospitalized for acute lower respiratory tract infection
• Complete hospitalization and clinical data available

Exclusion criteria

• Detection of additional respiratory pathogens on multiplex PCR
• Discharge against medical advice before treatment was completed
• Missing or incomplete key clinical, laboratory, or radiologic data
• ICU admission without full follow-up data

Trial design

209 participants in 1 patient group

RSV-Positive Children Aged 1-24 Months

Description:

This cohort includes children aged 1 to 24 months who were hospitalized with laboratory-confirmed RSV-positive acute lower respiratory tract infections between April 2017 and April 2021. Data were collected retrospectively at Dr. Behçet Uz Children's Hospital. No intervention was administered as part of the study; the investigation focused on clinical, laboratory, and radiologic factors influencing antibiotic use, as well as associated hospitalization costs.